Genome-wide association studies have shown that polymorphisms in the glucokinase regulatory protein are related to triglyceride level, obesity, insulin resistance/type II diabetes mellitus and dyslipidemia [14–17], common conditions associated with NAFLD disorder. Here, GCK is linked to metabolic dysfunction-associated steatotic liver disease.